Author:
Tromm Andreas,Bunganič Ivan,Tomsová Eva,Tulassay Zsolt,Lukáš Milan,Kykal Jan,Bátovský Marian,Fixa Bohumil,Gabalec Libor,Safadi Rifaat,Kramm Heinz–Jochen,Altorjay István,Löhr Hanns,Koutroubakis Ioannis,Bar–Meir Simon,Štimac Davor,Schäffeler Elke,Glasmacher Christoph,Dilger Karin,Mohrbacher Ralf,Greinwald Roland
Subject
Gastroenterology,Hepatology
Reference31 articles.
1. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management;Dignass;J Crohn Colitis,2010
2. Budesonide for induction of remission in Crohn's disease;Seow;Cochrane Database Syst Rev,2008
3. Metabolic pathways of the topical glucocorticoid budesonide in man;Edsbäcker;Drug Metab Dispos,1983
4. Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease;Schoon;Clin Gastroenterol Hepatol,2005
5. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver;Jonsson;Drug Metab Dispos,1995
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献